Luye Pharma Group (STU:LUP) Days Sales Outstanding : 108.71 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Luye Pharma Group Days Sales Outstanding?

Luye Pharma Group's average Accounts Receivable for the six months ended in Dec. 2023 was €247.8 Mil. Luye Pharma Group's Revenue for the six months ended in Dec. 2023 was €416.0 Mil. Hence, Luye Pharma Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 108.71.

The historical rank and industry rank for Luye Pharma Group's Days Sales Outstanding or its related term are showing as below:

STU:LUP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 68.14 Med: 86.1 Max: 105.25
Current: 105.25

During the past 13 years, Luye Pharma Group's highest Days Sales Outstanding was 105.25. The lowest was 68.14. And the median was 86.10.

STU:LUP's Days Sales Outstanding is ranked worse than
76.63% of 997 companies
in the Drug Manufacturers industry
Industry Median: 71.44 vs STU:LUP: 105.25

Luye Pharma Group's Days Sales Outstanding increased from Dec. 2022 (91.17) to Dec. 2023 (108.71).

Luye Pharma Group Days Sales Outstanding Historical Data

The historical data trend for Luye Pharma Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luye Pharma Group Days Sales Outstanding Chart

Luye Pharma Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

67.30

72.04

83.34

91.11

103.61

Luye Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															116.17	99.71	91.17	106.16	108.71

Competitive Comparison of Luye Pharma Group's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Luye Pharma Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Luye Pharma Group's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luye Pharma Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Luye Pharma Group's Days Sales Outstanding falls into.

Luye Pharma Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Luye Pharma Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (193.878	+	254.014)	/	2 )	/	788.942	*	365
=	223.946					/	788.942	*	365
=	103.61

Luye Pharma Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (241.572	+	254.014)	/	2 )	/	415.974	*	365 / 2
=	247.793					/	415.974	*	365 / 2
=	108.71

Luye Pharma Group (STU:LUP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Luye Pharma Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Luye Pharma Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Luye Pharma Group (STU:LUP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luye Pharma Group Ltd (STU:LUP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

LYPHF:USA 02186:Hong Kong LUP:Germany

Address

No. 15 Chuang Ye Road, High-tech Industrial Development Zone, Shandong, Yantai, CHN, 264003

Website

https://www.luye.cn

Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on developing, producing, and selling pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for global use in Asia, Europe, and the United States.

Luye Pharma Group (STU:LUP) Headlines

No Headlines